Brief: RedHill Biopharma Reports Q2 Loss Per Ordinary Share Of 6 Cents

Redhill Biopharma

26/08/2021 12:42

Aug 26 (Reuters) - RedHill Biopharma Ltd  REDIF.PK :
    * REDHILL BIOPHARMA REPORTS SECOND QUARTER 2021 FINANCIAL
RESULTS
AND OPERATIONAL HIGHLIGHTS
    * REDHILL BIOPHARMA LTD - QTRLY LOSS PER ORDINARY SHARE
$0.06
    * REDHILL BIOPHARMA LTD - NET REVENUES WERE APPROXIMATELY
$21.5
MILLION FOR Q2 OF 2021, AN INCREASE OF $0.9 MILLION COMPARED TO
Q1 OF 2021
    * REDHILL BIOPHARMA - CASH BALANCE AS OF JUNE 30, 2021, WAS
APPROXIMATELY $71.5 MILLION

Source text for Eikon:  ID:nCNWJprLla 
Further company coverage:  REDIF.PK 

 ((Reuters.Briefs@thomsonreuters.com;))